News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
170,411 Results
Type
Article (3789)
Company Profile (104)
Press Release (166517)
Section
Business (50086)
Career Advice (102)
Deals (8752)
Drug Delivery (5)
Drug Development (30781)
Employer Resources (13)
FDA (2744)
Job Trends (3441)
News (91020)
Policy (5957)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Standard (1)
Academia (207)
Accelerated approval (5)
Allergies (47)
Alliances (11573)
ALS (58)
Alzheimer's disease (425)
Antibody-drug conjugate (ADC) (102)
Approvals (2969)
Artificial intelligence (107)
Autoimmune disease (56)
Automation (5)
Bankruptcy (50)
Best Places to Work (3067)
BIOSECURE Act (2)
Biosimilars (77)
Biotechnology (69)
Bladder cancer (58)
Brain cancer (19)
Breast cancer (170)
Cancer (1598)
Cardiovascular disease (106)
Career advice (95)
Career pathing (2)
CAR-T (105)
CDC (1)
Cell therapy (209)
Cervical cancer (10)
Clinical research (28003)
Collaboration (502)
Compensation (651)
Complete response letters (9)
COVID-19 (419)
CRISPR (22)
C-suite (316)
Cystic fibrosis (35)
Data (2429)
Depression (54)
Diabetes (124)
Diagnostics (479)
Digital health (5)
Diversity, equity & inclusion (3)
Drug discovery (52)
Drug pricing (13)
Drug shortages (3)
Duchenne muscular dystrophy (46)
Earnings (23325)
Editorial (4)
Employer branding (1)
Employer resources (12)
Events (34903)
Executive appointments (364)
FDA (3754)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (6)
Funding (390)
Gene editing (45)
Generative AI (6)
Gene therapy (97)
GLP-1 (209)
Government (458)
Grass and pollen (2)
Guidances (129)
Healthcare (2138)
HIV (18)
Huntington's disease (9)
IgA nephropathy (20)
Immunology and inflammation (53)
Immuno-oncology (20)
Indications (45)
Infectious disease (467)
Inflammatory bowel disease (63)
Inflation Reduction Act (1)
Influenza (18)
Intellectual property (73)
Interviews (13)
IPO (5420)
IRA (4)
Job creations (532)
Job search strategy (86)
JPM (3)
Kidney cancer (8)
Layoffs (34)
Leadership (2)
Legal (738)
Liver cancer (21)
Longevity (3)
Lung cancer (257)
Lymphoma (149)
Machine learning (10)
Management (4)
Manufacturing (215)
MASH (89)
Medical device (691)
Medtech (694)
Mergers & acquisitions (3733)
Metabolic disorders (349)
Multiple sclerosis (61)
NASH (8)
Neurodegenerative disease (69)
Neuropsychiatric disorders (26)
Neuroscience (834)
NextGen: Class of 2026 (813)
Non-profit (264)
Now hiring (4)
Obesity (128)
Opinion (31)
Ovarian cancer (55)
Pain (51)
Pancreatic cancer (67)
Parkinson's disease (77)
Partnered (1)
Patents (127)
Patient recruitment (191)
Peanut (19)
People (16461)
Pharmaceutical (30)
Pharmacy benefit managers (1)
Phase 1 (8320)
Phase 2 (12716)
Phase 3 (9219)
Pipeline (1915)
Policy (15)
Postmarket research (496)
Preclinical (3080)
Press Release (11)
Prostate cancer (66)
Psychedelics (12)
Radiopharmaceuticals (111)
Rare diseases (227)
Real estate (992)
Recruiting (7)
Regulatory (5999)
Reports (8)
Research institute (257)
Resumes & cover letters (6)
Rett syndrome (3)
RNA editing (1)
RSV (14)
Schizophrenia (91)
Series A (60)
Series B (51)
Service/supplier (2)
Sickle cell disease (20)
Spinal muscular atrophy (44)
Sponsored (2)
Startups (822)
State (1)
Stomach cancer (1)
Supply chain (16)
Tariffs (8)
Vaccines (151)
Venture capital (8)
Weight loss (31)
Women's health (9)
Date
Today (5)
Last 7 days (170)
Last 30 days (631)
Last 365 days (10388)
2026 (952)
2025 (10489)
2024 (11815)
2023 (13424)
2022 (15426)
2021 (16993)
2020 (14550)
2019 (9607)
2018 (6851)
2017 (8597)
2016 (7046)
2015 (8865)
2014 (6628)
2013 (4730)
2012 (4719)
2011 (4675)
2010 (4622)
Location
Africa (93)
Alabama (18)
Arizona (33)
Arkansas (2)
Asia (12839)
Australia (1490)
California (4363)
Canada (794)
China (649)
Colorado (114)
Connecticut (169)
Delaware (184)
Europe (24262)
Florida (564)
Georgia (125)
Idaho (5)
Illinois (187)
India (16)
Indiana (120)
Iowa (9)
Japan (114)
Kansas (67)
Kentucky (10)
Maine (2)
Maryland (393)
Massachusetts (3226)
Michigan (45)
Minnesota (147)
Mississippi (1)
Missouri (22)
Montana (2)
Nebraska (5)
Nevada (16)
New Hampshire (6)
New Jersey (1348)
New Mexico (7)
New York (1344)
North Carolina (498)
Northern California (2303)
Ohio (107)
Oklahoma (5)
Oregon (13)
Pennsylvania (697)
Puerto Rico (2)
Rhode Island (5)
South America (137)
South Carolina (5)
Southern California (1665)
Tennessee (21)
Texas (444)
United States (14382)
Utah (70)
Virginia (85)
Washington D.C. (15)
Washington State (260)
Wisconsin (20)
170,411 Results for "paradigm biopharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
Amgen Wants MariTide To Change Obesity Paradigm With Longer Dosing Periods
Amgen believes that it can transcend the expected tradeoff between convenience and efficacy, anticipating that its investigational obesity drug MariTide will continue to provide competitive weight loss even at monthly or longer schedules.
February 4, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Bioprinting and Bio-inks: Shifting Paradigms in Regenerative Medicine and Future Economic Outlook, Commentary by unexakorea
January 2, 2026
·
1 min read
Opinion
Patient-Centered Paradigms Can Boost Neuro Candidate Success Rates
Innovative outcome measures coupled with a focus on patient-centered clinical differentiation can help the biopharma industry make meaningful progress in the highly complex area of neuroscience.
December 8, 2025
·
5 min read
·
Bruce Leuchter
Parexel and Paradigm Health Partner to Expand Access and Efficiency in Clinical Trials
September 16, 2025
·
4 min read
Press Releases
FDA Approves Anteris’s DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
November 4, 2025
·
4 min read
Cancer
ASH25: Late-Stage Data For J&J’s Tecvayli/Darzalex Combo Could ‘Shift Paradigm’ in Myeloma
Tecvayli plus Darzalex led to an 83% boost to progression-free survival versus the current standard therapy in relapsed or refractory multiple myeloma, results analysts at Guggenheim Securities called “remarkable.”
November 25, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Amphista Therapeutics presents new preclinical data showing the potential of its BRD9 Targeted Glue™, AMX-883, to transform the treatment paradigm for acute myeloid leukaemia
December 8, 2025
·
4 min read
Press Releases
Anteris Receives First European Regulatory Clearance to Commence DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
October 16, 2025
·
6 min read
Press Releases
Roivant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves’ Disease Patients
September 4, 2025
·
11 min read
Press Releases
Johnson & Johnson seeks first European Medicines Agency approval for icotrokinra aiming to transform the plaque psoriasis treatment paradigm
September 11, 2025
·
18 min read
1 of 17,042
Next
